病原微生物荚膜多糖的生物学功能

doi:10.11843/j.issn.0366-6964.2021.03.002

摘要/Abstract

摘要： 荚膜多糖（capsular polysaccharide，CPS）是一种广泛存在于细菌、支原体、部分真菌等菌体表面的碳水化合物。同时，荚膜多糖有助于菌体抵抗干燥和低温等不利环境，并通过在菌体表面形成物理屏障阻碍宿主补体的杀伤与吞噬作用。在长期多种应激-压力环境下，病原菌已进化出多种免疫逃避机制并促进宿主感染；在非病原微生物中，荚膜多糖可正向调节宿主免疫作用，并拮抗机体免疫因子，保护宿主免受病原菌引起的炎症性疾病。本文将结合本团队的相关研究工作，对荚膜多糖的结构、合成调控机制、生物学功能、免疫逃避机制和致病机制，特别是荚膜多糖正向调节宿主免疫系统及其应用潜力等方面作一综述，为病原菌致病机制的研究和疫病的有效防控提供参考依据。

关键词: 荚膜多糖, 合成调控机制, 免疫逃避, 致病机制, 免疫调节

Abstract: Capsular polysaccharide (CPS) is a carbohydrate that is widely present on the surface of bacteria, mycoplasma, and some fungi. At the same time, CPS can help the bacteria resist the adverse environment such as dry and low temperature, and block the killing of host complement and phagocytosis by forming a physical barrier on the surface of bacteria. Under long-term multiple stress environments, pathogens have evolved a variety of immune escape mechanisms and promote host infection; among non-pathogenic microorganisms, CPS can positively regulate host immune function, and antagonize immune factors, to protect the host from inflammatory diseases caused by pathogens. This article will combine the relevant research works of our team to review the structure, synthesis regulatory mechanisms, biological function, immune evasion mechanism and pathogenic mechanism of CPS, especially the positive regulation of the host immune system by CPS and its application potential, to provide references for the research on pathogenic mechanisms of pathogenic bacteria and effective prevention and control of epidemic diseases.

Key words: capsular polysaccharide, regulatory mechanism of synthesis, immune escape, pathogenic mechanism, immune regulation

中图分类号:

S852.6

谢黎卿, 杨洋, 彭远义, 李能章. 病原微生物荚膜多糖的生物学功能[J]. 畜牧兽医学报, 2021, 52(3): 576-587.

XIE Liqing, YANG Yang, PENG Yuanyi, LI Nengzhang. Research Progress on the Function and Immunity of Capsular Polysaccharide[J]. Acta Veterinaria et Zootechnica Sinica, 2021, 52(3): 576-587.

参考文献 94

[1]	DOCHEZ A R, AVERY O T. The elaboration of specific soluble substance by pneumococcus during growth[J]. J Exp Med, 1917, 26(4):477-493.
[2]	TOMCSIK J, BAUMANN-GRACE J B. Polysaccharide capsule of Bacillus megaterium[J]. Proc Soc Exp Biol Med, 1959, 101(3):570-571.
[3]	TYTGAT H L P, LEBEER S. The sweet tooth of bacteria:common themes in bacterial glycoconjugates[J]. Microbiol Mol Biol Rev, 2014, 78(3):372-417.
[4]	WILLIS L M, WHITFIELD C. Structure, biosynthesis, and function of bacterial capsular polysaccharides synthesized by ABC transporter-dependent pathways[J]. Carbohydr Res, 2013, 378:35-44.
[5]	FOUET A, MESNAGE S. Bacillus anthracis cell envelope components[J]. Curr Top Microbiol Immunol, 2002, 271:87-113.
[6]	KUTTEL M M, JACKSON G E, MAFATA M, et al. Capsular polysaccharide conformations in pneumococcal serotypes 19F and 19A[J]. Carbohydr Res, 2015, 406:27-33.
[7]	PEREIRA C L, GEISSNER A, ANISH C, et al. Chemical synthesis elucidates the immunological importance of a pyruvate modification in the capsular polysaccharide of streptococcus pneumoniae serotype 4[J]. Angew Chem Int Ed, 2015, 54(34):10016-10019.
[8]	TOWNSEND K M, BOYCE J D, CHUNG J Y, et al. Genetic organization of Pasteurella multocida cap Loci and development of a multiplex capsular PCR typing system[J]. J Clin Microbiol, 2001, 39(3):924-929.
[9]	BOYCE J D, CHUNG J Y, ADLER B. Genetic organisation of the capsule biosynthetic locus of Pasteurella multocida M1404(B:2)[J]. Vet Microbiol, 2000, 72(1-2):121-134.
[10]	DEANGELIS P L, PADGETT-MCCUE A J. Identification and molecular cloning of a chondroitin synthase from Pasteurella multocida type F[J]. J Biol Chem, 2000, 275(31):24124-24129.
[11]	PANDIT K K, SMITH J E. Capsular hyaluronic acid in Pasteurella multocida type A and its counterpart in type D[J]. Res Vet Sci, 1993, 54(1):20-24.
[12]	DEANGELIS P L, WHITE C L. Identification and molecular cloning of a heparosan synthase from Pasteurella multocida type D[J]. J Biol Chem, 2002, 277(9):7209-7213.
[13]	GUAN L J, XUE Y, DING W W, et al. Biosynthesis and regulation mechanisms of the Pasteurella multocida capsule[J]. Res Vet Sci, 2019, 127:82-90.
[14]	NURSE-LUCAS M, MCGEE L, HAWKINS P A, et al. Serotypes and genotypes of Streptococcus pneumoniae isolates from Trinidad and Tobago[J]. Int J Infect Dis, 2016, 46:100-106.
[15]	ZHENG Y Q, ZHANG X M, WANG X F, et al. ComE, an essential response regulator, negatively regulates the expression of the capsular polysaccharide locus and attenuates the bacterial virulence in Streptococcus pneumoniae[J]. Front Microbiol, 2017, 8:277.
[16]	GHOSH P, LUONG T T, SHAH M, et al. Adenylate kinase potentiates the capsular polysaccharide by modulating Cps2D in Streptococcus pneumoniae D39[J]. Exp Mol Med, 2018, 50(9):116.
[17]	MORONA J K, MILLER D C, MORONA R, et al. The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae[J]. J Infect Dis, 2004, 189(10):1905-1913.
[18]	WEIDENMAIER C, LEE J C. Structure and function of surface polysaccharides of Staphylococcus aureus[M]//BAGNOLI F, RAPPUOLI R, GRANDI G. Staphylococcus aureus:Microbiology, pathology, immunology, therapy and prophylaxis. Springer, 2017:57-93.
[19]	RAUSCH M, DEISINGER J P, ULM H, et al. Coordination of capsule assembly and cell wall biosynthesis in Staphylococcus aureus[J]. Nat Commun, 2019, 10(1):1404.
[20]	LUONG T T, LEE C Y. The arl locus positively regulates Staphylococcus aureus type 5 capsule via an mgrA-dependent pathway[J]. Microbiology, 2006, 152(10):3123-3131.
[21]	FLEUCHOT B, GUILLOT A, MÉZANGE C, et al. Rgg-associated SHP signaling peptides mediate cross-talk in streptococci[J]. PLoS One, 2013, 8(6):e66042.
[22]	XIE Z J, MENG K, YANG X L, et al. Identification of a quorum sensing system regulating capsule polysaccharide production and biofilm formation in Streptococcus zooepidemicus[J]. Front Cell Infect Microbiol, 2019, 9:121.
[23]	LEE K J, KIM J A, HWANG W, et al. Role of capsular polysaccharide (CPS) in biofilm formation and regulation of CPS production by quorum-sensing in Vibrio vulnificus[J]. Mol Microbiol, 2013, 90(4):841-857.
[24]	ZHAO L P, XUE T, SHANG F, et al. Staphylococcus aureus AI-2 quorum sensing associates with the KdpDE two-component system to regulate capsular polysaccharide synthesis and virulence[J]. Infect Immun, 2010, 78(8):3506-3515.
[25]	YADAV M K, VIDAL J E, GO Y Y, et al. The LuxS/AI-2 quorum-sensing system of Streptococcus pneumoniae is required to cause disease, and to regulate virulence- and metabolism-related genes in a rat model of middle ear infection[J]. Front Cell Infect Microbiol, 2018, 8:138.
[26]	SUN Y C, LI Y, LUO Q, et al. LuxS/AI-2 quorum sensing system in Edwardsiella piscicida promotes biofilm formation and pathogenicity[J]. Infect Immun, 2020, 88(5):e00907-19.
[27]	ZHANG Q X, QIN S J, HUANG Y, et al. Inhibitory and preventive effects of Lactobacillus plantarum FB-T9 on dental caries in rats[J]. J Oral Microbiol, 2019, 12(1):1703883.
[28]	MENG J, CHEN H M, LV Q, et al. The release of norepinephrine in C57BL/6 J mice treated with 6-hydroxydopamine (6-OHDA) is associated with translocations in enteric Escherichia coli via the QseC histidine kinase receptor[J]. Med Sci Monit, 2020, 26:e922986.[2021-01-04]. https://www.medscimonit.com/download/index/idArt/922986.
[29]	LEE S, GHOSH P, KWON H, et al. Induction of the pneumococcal vncRS operon by lactoferrin is essential for pneumonia[J]. Virulence, 2018, 9(1):1562-1575.
[30]	GHOSH P, SHAH M, RAVICHANDRAN S, et al. Pneumococcal VncR strain-specifically regulates capsule polysaccharide synthesis[J]. Front Microbiol, 2019, 10:2279.
[31]	肖云菊. 细菌双组分系统YycF/YycG对肺炎链球菌荚膜多糖和磷壁酸多糖生物合成的调控研究[D]. 重庆:重庆医科大学, 2020.XIAOY J. Study on two-component systems YycF/YycG regulating the biosynthesis of capsular polysaccharide and teichoic acids in Streptococcus pneumoniae[D]. Chongqing:Chongqing Medical University, 2020. (in Chinese)
[32]	CROSBY H A, TIWARI N, KWIECINSKI J M, et al. The Staphylococcus aureus ArlRS two-component system regulates virulence factor expression through MgrA[J]. Mol Microbiol, 2020, 113(1):103-122.
[33]	PANNEN D, FABISCH M, GAUSLING L, et al. Interaction of the RcsB response regulator with auxiliary transcription regulators in Escherichia coli[J]. J Biol Chem, 2016, 291(5):2357-2370.
[34]	彭丹. 肺炎克雷伯菌转录调控子RcsAB对荚膜多糖相关基因调控关系的研究[D]. 重庆:重庆医科大学, 2019.PENG D. Exploration of the relationship between the transcriptional regulator RcsAB and capsule polysaccharide-related genes in Klebsiella pneumoniae [D]. Chongqing:Chongqing Medical University, 2019. (in Chinese)
[35]	WUGEDITSCH T, PAIMENT A, HOCKING J, et al. Phosphorylation of Wzc, a tyrosine autokinase, is essential for assembly of group 1 capsular polysaccharides in Escherichia coli[J]. J Biol Chem, 2001, 276(4):2361-2371.
[36]	SOULAT D, JAULT J M, DUCLOS B, et al. Staphylococcus aureus operates protein-tyrosine phosphorylation through a specific mechanism[J]. J Biol Chem, 2006, 281(20):14048-14056.
[37]	CAZA M, KRONSTAD J W. The cAMP/protein kinase a pathway regulates virulence and adaptation to host conditions in Cryptococcus neoformans[J]. Front Cell Infect Microbiol, 2019, 9:212.
[38]	FERREIRA R B R, ANTUNES L C M, GREENBERG E P, et al. Vibrio parahaemolyticus ScrC modulates cyclic dimeric GMP regulation of gene expression relevant to growth on surfaces[J]. J Bacteriol, 2008, 190(3):851-860.
[39]	ROSEN D A, TWENTYMAN J, HUNSTAD D A. High levels of cyclic Di-GMP in Klebsiella pneumoniae attenuate virulence in the lung[J]. Infect Immun, 2018, 86(2):e00647-17.
[40]	CHO K H, TRYON R G, KIM J H. Screening for diguanylate cyclase (DGC) inhibitors mitigating bacterial biofilm formation[J]. Front Chem, 2020, 8:264.
[41]	DE OLIVEIRA GONÇALVES P J R, HUME C C D, FERREIRA A J, et al. Environmental interactions are regulated by temperature in Burkholderia seminalis TC3. 4. 2R3[J]. Sci Rep, 2019, 9:5486.
[42]	KEINHÖRSTER D, SALZER A, DUQUE-JARAMILLO A, et al. Revisiting the regulation of the capsular polysaccharide biosynthesis gene cluster in Staphylococcus aureus[J]. Mol Microbiol, 2019, 112(4):1083-1099.
[43]	TROXLER L J, WERREN J P, SCHAFFNER T O, et al. Carbon source regulates polysaccharide capsule biosynthesis in Streptococcus pneumoniae[J]. J Biol Chem, 2019, 294(46):17224-17238.
[44]	BRAVO Z, ORRUÑO M, PARADA C, et al. The long-term survival of Acinetobacter baumannii ATCC 19606T under nutrient-deprived conditions does not require the entry into the viable but non-culturable state[J]. Arch Microbiol, 2016, 198(5):399-407.
[45]	TIPTON K A, CHIN C Y, FAROKHYFAR M, et al. Role of capsule in resistance to disinfectants, host antimicrobials, and desiccation in Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2018, 62(12):e01188-18.
[46]	VESSELLA G, CASILLO A, FABOZZI A, et al. Synthesis of the tetrasaccharide repeating unit of the cryoprotectant capsular polysaccharide from Colwellia psychrerythraea 34H[J]. Org Biomol Chem, 2019, 17(12):3129-3140.
[47]	WESSELS M R. Capsular polysaccharide of group A Streptococcus[J]. Microbiol Spectr, 2019, 7(1):GPP3-0050-2018.
[48]	PORTER N T, MARTENS E C. The critical roles of polysaccharides in gut microbial ecology and physiology[J]. Annu Rev Microbiol, 2017, 71:349-369.
[49]	SCHEMBRI M A, DALSGAARD D, KLEMM P. Capsule shields the function of short bacterial adhesins[J]. J Bacteriol, 2004, 186(5):1249-1257.
[50]	TAHOUN A, MASUTANI H, EL-SHARKAWY H, et al. Capsular polysaccharide inhibits adhesion of Bifidobacterium longum 105-A to enterocyte-like Caco-2 cells and phagocytosis by macrophages[J]. Gut Pathog, 2017, 9:27.
[51]	PETRUZZI B, BRIGGS R E, TATUM F M, et al. Capsular polysaccharide interferes with biofilm formation by Pasteurella multocida Serogroup A[J]. mBio, 2017, 8(6):e01843-17.
[52]	ZENG Z S, ZHAN W E, WANG W Q, et al. Biofilm formation in Pseudoalteromonas lipolytica is related to IS5-like insertions in the capsular polysaccharide operon[J]. FEMS Microbiol Ecol, 2019, 95(6):fiz065.
[53]	DEFENDI F, THIELENS N M, CLAVARINO G, et al. The immunopathology of complement proteins and innate immunity in autoimmune disease[J]. Clin Rev Allergy Immunol, 2020, 58(2):229-251.
[54]	PATHAK A, BERGSTRAND J, SENDER V, et al. Factor H binding proteins protect division septa on encapsulated Streptococcus pneumoniae against complement C3b deposition and amplification[J]. Nat Commun, 2018, 9:3398.
[55]	HYAMS C, CAMBERLEIN E, COHEN J M, et al. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms[J]. Infect Immun, 2010, 78(2):704-715.
[56]	BEURSKENS F J, VAN SCHAARENBURG R A, TROUW L A. C1q, antibodies and anti-C1q autoantibodies[J]. Mol Immunol, 2015, 68(1):6-13.
[57]	TAKAHASHI S, AOYAGI Y, ADDERSON E E, et al. Capsular sialic acid limits C5a production on type Ⅲ group B streptococci[J]. Infect Immun, 1999, 67(4):1866-1870.
[58]	FISHELSON Z. Complement-related proteins in pathogenic organisms[J]. Springer Semin Immunopathol, 1994, 15(4):345-368.
[59]	周琪,贺现辉,阳巧梅,等. 副猪嗜血杆菌SC096株荚膜多糖抗猪肺泡巨噬细胞吞噬能力的研究[J]. 畜牧兽医学报, 2016, 47(6):1232-1238.ZHOU Q,HE X H,YANG Q M,et al. Role of capsular polysaccharide in Haemophilus parasuis SC096 strain anti-porcine alveolar macrophage phagocytosis[J]. Acta Veterinaria et Zootechnica Sinica, 2016, 47(6):1232-1238. (in Chinese)
[60]	WILSON B A, HO M F. Pasteurella multocida:from zoonosis to cellular microbiology[J]. Clin Microbiol Rev, 2013, 26(3):631-655.
[61]	MOXON E R, KROLL J S. The role of bacterial polysaccharide capsules as virulence factors[M]//JANN K, JANN B. Current Topics in Microbiology and Immunology. Berlin, Heidelberg:Springer, 1990, 150:65-85.
[62]	雷桂花. 牛源A型多杀性巴氏杆菌强弱毒株诱导IL-1β成熟与分泌差异的研究[D]. 重庆:西南大学, 2018.LEI G H. The differences of IL-1β secretion induced by high and low virulence Pasteurella multocida serotype A infection[D]. Chongqing:Southwest University, 2018. (in Chinese)
[63]	ARMISTEAD B, OLER E, ADAMS WALDORF K, et al. The double life of group B streptococcus:asymptomatic colonizer and potent pathogen[J]. J Mol Biol, 2019, 431(16):2914-2931.
[64]	DE LEON-RODRIGUEZ C M, FU M S, ÇORBALI M O, et al. The capsule of Cryptococcus neoformans modulates phagosomal pH through its acid-base properties[J]. mSphere, 2018, 3(5):e00437-18.
[65]	GRUENHEID S, LE MOUAL H. Resistance to antimicrobial peptides in Gram-negative bacteria[J]. FEMS Microbiol Lett, 2012, 330(2):81-89.
[66]	LAZZARO B P, ZASLOFF M, ROLFF J. Antimicrobial peptides:Application informed by evolution[J]. Science, 2020, 368(6490):eaau5480.
[67]	LLOBET E, TOMÁS J M, BENGOECHEA J A. Capsule polysaccharide is a bacterial decoy for antimicrobial peptides[J]. Microbiology, 2008, 154(12):3877-3886.
[68]	HALE J D F, HANCOCK R E W. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria[J]. Expert Rev Anti Infect Ther, 2007, 5(6):951-959.
[69]	GRYLLOS I, TRAN-WINKLER H J, CHENG M F, et al. Induction of group A Streptococcus virulence by a human antimicrobial peptide[J]. Proc Natl Acad Sci U S A, 2008, 105(43):16755-16760.
[70]	SPINOSA M R, PROGIDA C, TALÀ A, et al. The Neisseria meningitidis capsule is important for intracellular survival in human cells[J]. Infect Immun, 2007, 75(7):3594-3603.
[71]	DEGHMANE A E, GIORGINI D, LARRIBE M, et al. Down-regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein[J]. Mol Microbiol, 2002, 43(6):1555-1564.
[72]	王楷宬, 陆承平, 范伟兴. 细菌荚膜多糖[J]. 微生物学报, 2011, 51(12):1578-1584.WANG K C, LU C P, FAN W X. Bacterial capsular polysaccharide-A review[J]. Acta Microbiologica Sinica, 2011, 51(12):1578-1584. (in Chinese)
[73]	JONG A, WU C H, GONZALES-GOMEZ I, et al. Hyaluronic acid receptor CD44 deficiency is associated with decreased Cryptococcus neoformans brain infection[J]. J Biol Chem, 2012, 287(19):15298-15306.
[74]	JIANG Z J, SONG F Y, LI Y N, et al. Capsular polysaccharide of Mycoplasma ovipneumoniae induces sheep airway epithelial cell apoptosis via ROS-dependent JNK/P38 MAPK pathways[J]. Oxid Med Cell Longev, 2017, 2017:6175841.
[75]	FANG R D, LEI G H, JIANG J L, et al. High- and low-virulent bovine Pasteurella multocida induced differential NLRP3 inflammasome activation and subsequent IL-1β secretion[J]. Vet Microbiol, 2020, 243:108646.
[76]	JANDHYALA S M, TALUKDAR R, SUBRAMANYAM C, et al. Role of the normal gut microbiota[J]. World J Gastroenterol, 2015, 21(29):8787-8803.
[77]	LIU Q, YU Z M, TIAN F W, et al. Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier[J]. Microb Cell Fact, 2020, 19(1):23.
[78]	AVCI F Y, KASPER D L. How bacterial carbohydrates influence the adaptive immune system[J]. Annu Rev Immunol, 2010, 28:107-130.
[79]	HSIEH S A, ALLEN P M. Immunomodulatory roles of polysaccharide capsules in the intestine[J]. Front Immunol, 2020, 11:690.
[80]	TROY E B, KASPER D L. Beneficial effects of Bacteroides fragilis polysaccharides on the immune system[J]. Front Biosci, 2010, 15:25-34.
[81]	BLANDFORD L E, JOHNSTON E L, SANDERSON J D, et al. Promoter orientation of the immunomodulatory Bacteroides fragilis capsular polysaccharide A (PSA) is off in individuals with inflammatory bowel disease (IBD)[J]. Gut Microbes, 2019, 10(5):569-577.
[82]	OCHOA-REPÁRAZ J, MIELCARZ D W, DITRIO L E, et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression[J]. J Immunol, 2010, 185(7):4101-4108.
[83]	ERTURK-HASDEMIR D, KASPER D L. Finding a needle in a haystack:Bacteroides fragilis polysaccharide A as the archetypical symbiosis factor[J]. Ann N Y Acad Sci, 2018, 1417(1):116-129.
[84]	MAZMANIAN S K, LIU C H, TZIANABOS A O, et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system[J]. Cell, 2005, 122(1):107-118.
[85]	RAMAKRISHNA C, KUJAWSKI M, CHUG H, et al. Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis[J]. Nat Commun, 2019, 10(1):2153.
[86]	CRESS B F, ENGLAENDER J A, HE W Q, et al. Masquerading microbial pathogens:capsular polysaccharides mimic host-tissue molecules[J]. FEMS Microbiol Rev, 2014, 38(4):660-697.
[87]	OCHOA-REPÁRAZ J, MIELCARZ D W, WANG Y, et al. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease[J]. Mucosal Immunol, 2010, 3(5):487-495.
[88]	GORREJA F, RUSH S T A, KASPER D L, et al. The developmentally regulated fetal enterocyte gene, ZP4, mediates anti-inflammation by the symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis[J]. Am J Physiol Gastrointest Liver Physiol, 2019, 317(4):G398-G407.
[89]	RAMAKRISHNA C, CANTIN E M. IFN gamma inhibits G-CSF induced neutrophil expansion and invasion of the CNS to prevent viral encephalitis[J]. PLoS Pathog, 2018, 14(1):e1006822.
[90]	JOHNSON J L, JONES M B, COBB B A. Bacterial capsular polysaccharide prevents the onset of asthma through T-cell activation[J]. Glycobiology, 2015, 25(4):368-375.
[91]	JOHNSON J L, JONES M B, COBB B A. Polysaccharide-experienced effector T cells induce IL-10 in FoxP3+ regulatory T cells to prevent pulmonary inflammation[J]. Glycobiology, 2018, 28(1):50-58.
[92]	CARRERAS-ABAD C, RAMKHELAWON L, HEATH P T, et al. A vaccine against group B Streptococcus:Recent advances[J]. Infect Drug Resist, 2020, 13:1263-1272.
[93]	GOYETTE-DESJARDINS G, CALZAS C, SHIAO T C, et al. Protection against Streptococcus suis serotype 2 infection using a capsular polysaccharide glycoconjugate vaccine[J]. Infect Immun, 2016, 84(7):2059-2075.
[94]	XU L L, LI Z J, SU Z G, et al. Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein[J]. Vaccine, 2019, 37(7):956-964.